Skip to content

Rural MOUD Telemedicine in Primary Care Phase 1

Rural Expansion of Medication Treatment for Opioid Use Disorder (Rural MOUD): Phase 1 Feasibility Study (CTN-0102)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04418453
Acronym
Feasibility
Enrollment
36762
Registered
2020-06-05
Start date
2020-06-01
Completion date
2021-11-05
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-use Disorder

Keywords

Medication treatment for opioid use disorder, Telemedicine, Rural areas

Brief summary

The feasibility study (Phase 1) will examine the implementation of telemedicine (TM) in six rural clinics in two states/regions with varying levels of OBOT capacity.

Detailed description

The dramatic increases in opioid overdose deaths across the nation, particularly in rural areas, call for a rapid expansion of access to medication treatment for opioid use disorder (MOUD).There is a need to study effective ways to expand treatment access and improve retention on MOUD in rural areas highly impacted by OUD. Telemedicine (TM) for MOUD offers an alternative or supplementary approach to delivering MOUD that may be suitable for rural clinics and patients with OUD. The objectives of the feasibility study are to study ways of incorporating TM into primary care clinics and to evaluate the associated outcomes, based on EHRs from the clinics and the TM vendor (i.e., patient days on MOUD) and participant surveys (e.g., opioid use). Additional outcomes of the feasibility study are feasibility and acceptability assessed from the perspectives of providers and participants via focus groups. A patient registry will be established in each clinic to track patients with OUD diagnoses, and those in the registry will be provided the opportunity to consent for sharing identified EHRs and participating in the follow-up surveys.

Interventions

OTHERIntegration of telemedicine for MOUD in primary care

Patients with opioid use disorder in rural primary care settings may be referred to receive telemedicine for medication treatment for opioid use disorder

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of California, Los Angeles
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-80 years old, inclusive, at the time of the qualifying visit * with OUD diagnosis * At least 1 visit to the participating clinics from 9 months before and 6 months after the date of intervention implementation

Design outcomes

Primary

MeasureTime frameDescription
Patient days on MOUD from Electronic Health Records (EHR)9 monthsNumber of days patients receive MOUD based on EHR data

Secondary

MeasureTime frameDescription
Number of OUD patients initiating/receiving MOUD9 monthsNumber of OUD patients initiating/receiving MOUD

Other

MeasureTime frameDescription
Treatment retention3 monthsNumber of patients retained in treatment at 3 months post baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026